- Home - Diagnos
Diagnos is a leader in artificial intelligence and healthcare technical services including algorithm development, data analysis, and image processing ever since 2001
- About us - Diagnos
During his career, he led teams to sell and implement complex infrastructure solution in health care provider and hospitals while bringing double digit growth in revenue for this vertical market His experience, leadership and business acumen will contribute to the rapid growth of Diagnos
- DIAGNOS Provides Update on its Health Canada Medical Device Licence . . .
Following the submission of its application in early September, DIAGNOS has engaged in ongoing communication with Health Canada, providing timely responses to all regulatory requests
- DIAGNOS Financial Statements
DIAGNOS Inc (“the Corporation”) is incorporated under the Canada Business Corporations Act and the subsidiaries under the applicable regulations in their respective countries
- Press Releases - Diagnos
2021-11-23, DIAGNOS will start a clinical trial study in the USA commencing December 6th, 2021 for early detection and prevention of Stroke using CARA-STROKE – Download PDF
- DIAGNOS Passes Annual MDSAP Audit, Solidifying the Pathway to Approvals . . .
By leveraging Artificial Intelligence, DIAGNOS aims to provide more information to healthcare clinicians to enhance diagnostic accuracy, streamline workflows, and improve patient outcomes on a global scale
- DIAGNOS MD A
Meeting regulatory compliance for medical devices ensures public safety by requiring manufacturers, such as DIAGNOS, to demonstrate the safety, efficacy, and quality of their products before and during commercialization
- DIAGNOS Announces Closing of Private Placement
By leveraging Artificial Intelligence, DIAGNOS aims to provide more information to healthcare clinicians to enhance diagnostic accuracy, streamline workflows, and improve patient outcomes on a global scale
|